If you live in Florida, you can ask a licensed doctor at Gentle Health whether Zepbound is appropriate for you. Our doctor reviews your health history online, decides whether a video visit is needed, and, if prescribing is appropriate, sends your prescription to LillyDirect. You buy the medicine there. Doctor care with us is $28 a month; the LillyDirect medicine price is separate. A prescription is never guaranteed.
That two-part price matters when you compare telehealth practices. Our published brand-name price comparison shows ongoing month-to-month doctor care at $149 a month at Ro and Hims & Hers, versus our $28 fee, as checked October 19, 2026. Both advertise a $39 first month; Ro also has a cheaper monthly-equivalent fee if you prepay a year. Compare the full arrangement, not just its opening price.
Starting care from Florida
In Florida, a licensed physician reviews your medical intake online and decides whether a video visit is needed. You can ask for video even if the review could be completed in writing. The doctor considers your conditions, other medicines, and whether Zepbound is appropriate before sending any prescription. The online start does not waive a clinical evaluation.
James Simmons, MD, holds Florida medical license ME183513. You can check it through the Florida Department of Health practitioner search. We serve patients in Jacksonville, Miami, Tampa, Orlando, St. Petersburg and other Florida communities where our service is available. See the Florida Zepbound service page for the current local details.
Gentle Health serves adults 18 and older. Zepbound is FDA-approved for long-term weight management in adults with obesity, or overweight with at least one weight-related condition, alongside changes to diet and physical activity. It also has an indication for moderate to severe obstructive sleep apnea in adults with obesity. The Zepbound prescribing information describes contraindications, including a personal or family history of medullary thyroid carcinoma or MEN2.
LillyDirect vials and KwikPen prices
Our doctor can prescribe Zepbound single-dose vials or the KwikPen. LillyDirect lists the same self-pay ladder for both: $299 for a 2.5 mg four-week supply, $399 for 5 mg, and $449 for 7.5–15 mg when the refill purchase qualifies under the 45-day rule, as of October 19, 2026. If that window is missed, the regular price is $499 at 7.5 mg or $699 at 10–15 mg (LillyDirect terms). A LillyDirect month is 28 days, not a calendar month.
Add $28 each calendar month for our doctor’s care. Messaging and video visits are included, with no prepayment or per-visit fee. You owe the care fee only once the doctor writes a prescription; there is no minimum commitment, and you can cancel any time. You pay LillyDirect for the medicine and buy any required supplies separately. Gentle Health does not sell, ship, or dispense Zepbound.
The vial is one weekly dose that you draw up with a needle and syringe. The KwikPen contains four weekly doses and needs a new pen needle each week. LillyDirect says both supplies are purchased separately. The single-dose autoinjector pen is a different product sold through the insurance route; we do not prescribe it. The device differences are explained in Zepbound vial versus KwikPen.
What happens after the prescription
If the doctor prescribes Zepbound, the prescription goes to LillyDirect Pharmacy. Make sure your phone number and email are current: the dispensing pharmacy uses them to send checkout instructions. Lilly asks patients to allow at least 3–5 business days for prescription verification; most orders ship 1–4 days after checkout, with free home delivery (LillyDirect FAQ). Those are Lilly’s process estimates, not a promised delivery date.
If your dose changes, our doctor must send a new prescription. For the $449 higher-dose offer, complete the refill purchase within 45 days of receiving the previous fill. Buying after that can sharply raise the medicine charge, so put the expected refill date on your calendar. Our online Zepbound guide covers the full pharmacy handoff.
Insurance and Medicare in Florida
Gentle Health does not bill insurance or handle prior authorizations. If a commercial plan covers Zepbound, an insured route may cost less than LillyDirect self-pay; ask your plan about the covered device, authorization rules and pharmacy. Do not assume your Florida Medicaid plan covers weight management: check its current drug list and requirements directly.
Eligible Florida Medicare beneficiaries may instead qualify for the Medicare GLP-1 Bridge, which lists the Zepbound KwikPen for weight management with a $50 copay. The program runs from July 1, 2026, through December 31, 2027, and has clinical eligibility and plan-approval requirements. The Zepbound vial is not the Bridge product. See the CMS provider explanation, page last modified August 6, 2026. That route uses Medicare approval, not our self-pay arrangement.
If you are comparing a compounded option, our Florida GLP-1 guide explains it separately. Compounded tirzepatide is not FDA-approved and is not a generic or equivalent version of Zepbound. Gentle Health is not affiliated with Eli Lilly.
Frequently asked questions
Can I start a Zepbound request online in Florida? Yes. The doctor reviews your intake online and decides whether video is needed before deciding whether to prescribe. A prescription is never guaranteed.
Where can I verify your Florida doctor? Search James Simmons, MD, license ME183513 in the Florida Department of Health database.
How much is Zepbound through Gentle Health? Care is $28 a month, and you buy the medicine from LillyDirect. As of October 19, 2026, its four-week self-pay price starts at $299 for 2.5 mg.
Does your Florida service bill insurance? No. We provide self-pay doctor care and send an appropriate prescription to LillyDirect. Ask your plan about a covered insurance route before choosing self-pay.
Does LillyDirect’s $449 higher-dose price always apply? No. At 7.5–15 mg it depends on a refill purchase within 45 days of the previous delivery. The regular price is higher if the offer’s conditions are missed.
Dr. James Simmons, MD